Cubist Systematic Strategies’s Viking Therapeutics VKTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.8M | Buy |
+596,650
| New | +$15.8M | 0.07% | 151 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 2331 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 2341 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 2284 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 2639 |
|
2024
Q1 | – | Sell |
-79,459
| Closed | -$1.48M | – | 2843 |
|
2023
Q4 | $1.48M | Buy |
+79,459
| New | +$1.48M | 0.01% | 949 |
|
2023
Q3 | – | Sell |
-222,587
| Closed | -$3.61M | – | 2614 |
|
2023
Q2 | $3.61M | Buy |
222,587
+9,341
| +4% | +$151K | 0.02% | 622 |
|
2023
Q1 | $3.55M | Sell |
213,246
-134,271
| -39% | -$2.24M | 0.02% | 797 |
|
2022
Q4 | $3.27M | Buy |
347,517
+57,245
| +20% | +$538K | 0.02% | 969 |
|
2022
Q3 | $790K | Sell |
290,272
-41,264
| -12% | -$112K | ﹤0.01% | 2222 |
|
2022
Q2 | $958K | Buy |
331,536
+49,230
| +17% | +$142K | 0.01% | 2146 |
|
2022
Q1 | $847K | Buy |
282,306
+239,182
| +555% | +$718K | 0.01% | 2165 |
|
2021
Q4 | $198K | Buy |
+43,124
| New | +$198K | ﹤0.01% | 3033 |
|
2021
Q3 | – | Sell |
-21,810
| Closed | -$131K | – | 3193 |
|
2021
Q2 | $131K | Sell |
21,810
-7,359
| -25% | -$44.2K | ﹤0.01% | 2679 |
|
2021
Q1 | $184K | Buy |
29,169
+4,704
| +19% | +$29.7K | ﹤0.01% | 2501 |
|
2020
Q4 | $138K | Sell |
24,465
-1,782
| -7% | -$10.1K | ﹤0.01% | 2354 |
|
2020
Q3 | $153K | Sell |
26,247
-1,202
| -4% | -$7.01K | ﹤0.01% | 2199 |
|
2020
Q2 | $198K | Buy |
+27,449
| New | +$198K | ﹤0.01% | 2040 |
|
2019
Q3 | – | Sell |
-129,196
| Closed | -$1.07M | – | 2507 |
|
2019
Q2 | $1.07M | Buy |
+129,196
| New | +$1.07M | 0.02% | 1004 |
|
2019
Q1 | – | Sell |
-89,783
| Closed | -$687K | – | 2432 |
|
2018
Q4 | $687K | Buy |
+89,783
| New | +$687K | 0.03% | 763 |
|
2018
Q3 | – | Sell |
-13,600
| Closed | -$129K | – | 2075 |
|
2018
Q2 | $129K | Buy |
+13,600
| New | +$129K | 0.01% | 1469 |
|